Home NDC 0310-4535 IMJUDO
Product NDC 0310-4535
11-digit product format 003104535
Labeler code 0310
Product ID 0310-4535_390ff583-8e40-4690-ac4c-b4eaef2229d2
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name tremelimumab
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler AstraZeneca Pharmaceuticals LP
Application BLA761289
Marketing category BLA
Marketing start 2022-10-21
Substance TREMELIMUMAB
Active strength 300 mg/15mL
Pharmacologic classes CTLA-4-directed Antibody Interactions [MoA], CTLA-4-directed Blocking Antibody [EPC], Increased T Lymphocyte Activation [PE]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base IMJUDO
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TREMELIMUMAB 300 mg/15mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination QEN1X95CIX Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2619317 Internal RxNorm lookup 2619323 Internal RxNorm lookup 2619325 Internal RxNorm lookup 2619326 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0310-4535-30 IMJUDO 1 in 1 CARTON INJECTION, SOLUTION 1 14 0310-4535-30 IMJUDO 15 mL in 1 VIAL INJECTION, SOLUTION 15 14
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0310-4535 IMJUDO (TREMELIMUMAB) INJECTION, SOLUTION [ASTRAZENECA PHARMACEUTICALS LP] 11 Current NDC, Legacy NDC, 2 package rows 20240802_6690679c-be2f-4588-a2e4-89fff74dd6be.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761289 Imjudo tremelimumab-actl 351(a) Rx 2026-07-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0310-4535-30 00310453530 1 VIAL in 1 CARTON (0310-4535-30) / 15 mL in 1 VIAL 1 vial 2022-10-21 0000-00-00 No No Current